BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.07.25 | Richemont Hold | Deutsche Bank AG | |
| 23.07.25 | Givaudan Neutral | UBS AG | |
| 23.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 23.07.25 | Givaudan Equal Weight | Barclays Capital | |
| 22.07.25 | Givaudan Add | Baader Bank | |
| 22.07.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.25 | Givaudan Neutral | UBS AG | |
| 22.07.25 | Roche Sell | Deutsche Bank AG | |
| 22.07.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | Novartis Neutral | UBS AG | |
| 21.07.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 21.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 21.07.25 | Richemont Sector Perform | RBC Capital Markets | |
| 21.07.25 | Nestlé Equal Weight | Barclays Capital | |
| 21.07.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 18.07.25 | Novartis Kaufen | DZ BANK | |
| 18.07.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 18.07.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.07.25 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 18.07.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 18.07.25 | Novartis Buy | Deutsche Bank AG | |
| 18.07.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.07.25 | Nestlé Market-Perform | Bernstein Research | |
| 18.07.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.07.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.07.25 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 17.07.25 | Novartis Outperform | Bernstein Research | |
| 17.07.25 | Novartis Hold | Jefferies & Company Inc. | |
| 17.07.25 | Novartis Neutral | UBS AG | |
| 17.07.25 | Richemont Buy | UBS AG | |
| 17.07.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 17.07.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 17.07.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 17.07.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.07.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 16.07.25 | Zurich Insurance Equal Weight | Barclays Capital |